+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Immunotherapy"

Abemaciclib Market Report 2025 - Product Thumbnail Image

Abemaciclib Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
CTLA4 Inhibitors Market Report 2025 - Product Thumbnail Image

CTLA4 Inhibitors Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2025 - Product Thumbnail Image

Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Head and Neck Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Polyclonal Antibodies Market Report 2025 - Product Thumbnail Image

Polyclonal Antibodies Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Tumor Infiltrating Lymphocytes Market Report 2025 - Product Thumbnail Image

Tumor Infiltrating Lymphocytes Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
TCR Therapy Market Report 2025 - Product Thumbnail Image

TCR Therapy Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
BCL-2 Inhibitors Market Report 2025 - Product Thumbnail Image

BCL-2 Inhibitors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
Checkpoint Inhibitors Market Report 2025 - Product Thumbnail Image

Checkpoint Inhibitors Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Drugs for Immunotherapy Market Report 2025 - Product Thumbnail Image

Drugs for Immunotherapy Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
T-Cell Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

T-Cell Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
From
T-Cell Malignancies - Pipeline Insight, 2025 - Product Thumbnail Image

T-Cell Malignancies - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 280 Pages
  • Global
From
NK Cell Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

NK Cell Therapies - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Interleukin-12 Expression Stimulants - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-12 Expression Stimulants - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Anal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Anal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer. Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes. Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more